Cargando…

Use of Sysmex XN‐10 red blood cell parameters for screening of hereditary red blood cell diseases and iron deficiency anaemia

INTRODUCTION: In daily practice in haematology laboratories, red blood cell (RBC) abnormalities are frequent and their management is a real challenge. The aim of this study is to establish a “decision tree” using RBC and reticulocyte parameters from the SYSMEX XN‐10 analyser to distinguish between p...

Descripción completa

Detalles Bibliográficos
Autores principales: Nivaggioni, Vanessa, Bouriche, Lakhdar, Coito, Sylvie, Le Floch, Anne‐Sophie, Ibrahim‐Kosta, Manal, Leonnet, Caroline, Arnoux, Isabelle, Loosveld, Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754411/
https://www.ncbi.nlm.nih.gov/pubmed/32639680
http://dx.doi.org/10.1111/ijlh.13278
_version_ 1783626188988612608
author Nivaggioni, Vanessa
Bouriche, Lakhdar
Coito, Sylvie
Le Floch, Anne‐Sophie
Ibrahim‐Kosta, Manal
Leonnet, Caroline
Arnoux, Isabelle
Loosveld, Marie
author_facet Nivaggioni, Vanessa
Bouriche, Lakhdar
Coito, Sylvie
Le Floch, Anne‐Sophie
Ibrahim‐Kosta, Manal
Leonnet, Caroline
Arnoux, Isabelle
Loosveld, Marie
author_sort Nivaggioni, Vanessa
collection PubMed
description INTRODUCTION: In daily practice in haematology laboratories, red blood cell (RBC) abnormalities are frequent and their management is a real challenge. The aim of this study is to establish a “decision tree” using RBC and reticulocyte parameters from the SYSMEX XN‐10 analyser to distinguish between patients with a hereditary RBC disease from iron deficiency anaemia and other patients. METHODS: We analysed results of complete RBC counts in a cohort composed of 8217 adults divided into 5 different groups: iron deficiency anaemia (n = 120), heterozygous haemoglobinopathy (n = 92), sickle cell disease syndrome (n = 56), hereditary spherocytosis (n = 18) and other patients (n = 7931). A Classification And Regression Tree (CART) analysis was used to obtain a two‐step decision tree in order to predict these previous groups. RESULTS: Five parameters and the calculated RBC score were selected by the CART method: mean corpuscular haemoglobin concentration, percentage of microcytes, distribution width of the RBC histogram, percentage of nucleated red blood cells, immature reticulocytes fraction and finally RBC Score. When applying the tree and recommended flowchart, 158/166 of the RBC hereditary disease patients and 114/120 iron deficiency anaemia patients are detected. Overall, the correct classification rate reached 99.4%. Sensitivity and specificity for RBC disease detection were 95.2% and 99.9%, respectively. These results were confirmed in an independent validation cohort. CONCLUSION: Based on the XN‐10 RBC and reticulocyte parameters, we propose a two‐step decision tree delivering a good prediction and classification of hereditary RBC diseases. These results can be used to optimize additional reticulocyte analysis and microscopy review.
format Online
Article
Text
id pubmed-7754411
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-77544112020-12-23 Use of Sysmex XN‐10 red blood cell parameters for screening of hereditary red blood cell diseases and iron deficiency anaemia Nivaggioni, Vanessa Bouriche, Lakhdar Coito, Sylvie Le Floch, Anne‐Sophie Ibrahim‐Kosta, Manal Leonnet, Caroline Arnoux, Isabelle Loosveld, Marie Int J Lab Hematol ORIGINAL ARTICLES INTRODUCTION: In daily practice in haematology laboratories, red blood cell (RBC) abnormalities are frequent and their management is a real challenge. The aim of this study is to establish a “decision tree” using RBC and reticulocyte parameters from the SYSMEX XN‐10 analyser to distinguish between patients with a hereditary RBC disease from iron deficiency anaemia and other patients. METHODS: We analysed results of complete RBC counts in a cohort composed of 8217 adults divided into 5 different groups: iron deficiency anaemia (n = 120), heterozygous haemoglobinopathy (n = 92), sickle cell disease syndrome (n = 56), hereditary spherocytosis (n = 18) and other patients (n = 7931). A Classification And Regression Tree (CART) analysis was used to obtain a two‐step decision tree in order to predict these previous groups. RESULTS: Five parameters and the calculated RBC score were selected by the CART method: mean corpuscular haemoglobin concentration, percentage of microcytes, distribution width of the RBC histogram, percentage of nucleated red blood cells, immature reticulocytes fraction and finally RBC Score. When applying the tree and recommended flowchart, 158/166 of the RBC hereditary disease patients and 114/120 iron deficiency anaemia patients are detected. Overall, the correct classification rate reached 99.4%. Sensitivity and specificity for RBC disease detection were 95.2% and 99.9%, respectively. These results were confirmed in an independent validation cohort. CONCLUSION: Based on the XN‐10 RBC and reticulocyte parameters, we propose a two‐step decision tree delivering a good prediction and classification of hereditary RBC diseases. These results can be used to optimize additional reticulocyte analysis and microscopy review. John Wiley and Sons Inc. 2020-07-08 2020-12 /pmc/articles/PMC7754411/ /pubmed/32639680 http://dx.doi.org/10.1111/ijlh.13278 Text en © 2020 The Authors. International Journal of Laboratory Hematology published by John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle ORIGINAL ARTICLES
Nivaggioni, Vanessa
Bouriche, Lakhdar
Coito, Sylvie
Le Floch, Anne‐Sophie
Ibrahim‐Kosta, Manal
Leonnet, Caroline
Arnoux, Isabelle
Loosveld, Marie
Use of Sysmex XN‐10 red blood cell parameters for screening of hereditary red blood cell diseases and iron deficiency anaemia
title Use of Sysmex XN‐10 red blood cell parameters for screening of hereditary red blood cell diseases and iron deficiency anaemia
title_full Use of Sysmex XN‐10 red blood cell parameters for screening of hereditary red blood cell diseases and iron deficiency anaemia
title_fullStr Use of Sysmex XN‐10 red blood cell parameters for screening of hereditary red blood cell diseases and iron deficiency anaemia
title_full_unstemmed Use of Sysmex XN‐10 red blood cell parameters for screening of hereditary red blood cell diseases and iron deficiency anaemia
title_short Use of Sysmex XN‐10 red blood cell parameters for screening of hereditary red blood cell diseases and iron deficiency anaemia
title_sort use of sysmex xn‐10 red blood cell parameters for screening of hereditary red blood cell diseases and iron deficiency anaemia
topic ORIGINAL ARTICLES
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754411/
https://www.ncbi.nlm.nih.gov/pubmed/32639680
http://dx.doi.org/10.1111/ijlh.13278
work_keys_str_mv AT nivaggionivanessa useofsysmexxn10redbloodcellparametersforscreeningofhereditaryredbloodcelldiseasesandirondeficiencyanaemia
AT bourichelakhdar useofsysmexxn10redbloodcellparametersforscreeningofhereditaryredbloodcelldiseasesandirondeficiencyanaemia
AT coitosylvie useofsysmexxn10redbloodcellparametersforscreeningofhereditaryredbloodcelldiseasesandirondeficiencyanaemia
AT leflochannesophie useofsysmexxn10redbloodcellparametersforscreeningofhereditaryredbloodcelldiseasesandirondeficiencyanaemia
AT ibrahimkostamanal useofsysmexxn10redbloodcellparametersforscreeningofhereditaryredbloodcelldiseasesandirondeficiencyanaemia
AT leonnetcaroline useofsysmexxn10redbloodcellparametersforscreeningofhereditaryredbloodcelldiseasesandirondeficiencyanaemia
AT arnouxisabelle useofsysmexxn10redbloodcellparametersforscreeningofhereditaryredbloodcelldiseasesandirondeficiencyanaemia
AT loosveldmarie useofsysmexxn10redbloodcellparametersforscreeningofhereditaryredbloodcelldiseasesandirondeficiencyanaemia